Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07778888 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial

Study acronym: BRIGHT
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Trial RX01-BL1107-1202 is designed to identify the lowest effective concentration of BL1107 required for complete resolution of conjunctival hyperemia in participants with DED. Participants will be masked to concentration of BL1107 received.
Trial Details
NCT Number NCT07778888
Lead Sponsor Bausch & Lomb Incorporated
Conditions
(from sponsor)		 Dry Eye Disease
Related terms Dry Eye Syndromes
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov